Pathway Analysis for Design of Promiscuous Drugs and Selective Drug Mixtures

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|3|4|269-277

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.3, Iss.4, 2006-12, pp. : 269-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs

By  

Current Medicinal Chemistry, Vol. 22, Iss. 4, 2015-02 ,pp. : 438-464

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterial Shikimate Pathway Enzymes as Targets for Drug Design

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 423-435

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-aided retrometabolic drug design: soft drugs

By Buchwald Peter  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 7, 2007-07 ,pp. : 923-933

Informa Healthcare

Access to resources Recommend Favorite

Molecular design and drug delivery of genetic drugs

By  

European Journal of Pharmaceutical Sciences, Vol. 13, Iss. 1, 2001-04 ,pp. : 1-1

Elsevier

Access to resources Recommend Favorite

On the Paradigm Shift Towards Multitarget Selective Drug Design

By  

Current Computer - Aided Drug Design, Vol. 4, Iss. 2, 2008-06 ,pp. : 76-90

Bentham Science Publishers

Access to resources Recommend Favorite